De Burlo Group’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

De Burlo Group’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-3,100	Closed	-$535K	–	112
2015 Q1	$535K	Sell	3,100 -200	-6%	-$29.4K	0.11%	81
2014 Q4	$379K	Sell	3,300 -78,900	-96%	-$9.56M	0.08%	90
2014 Q3	$12.8M	Buy	82,200 +4,700	+6%	+$681K	2.84%	5
2014 Q2	$9.56M	Buy	77,500 +5,400	+7%	+$597K	2.16%	14
2014 Q1	$7.47M	Buy	+72,100	New	+$7.38M	1.8%	20

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

De Burlo Group's SLXP Position: Q2 2015 in Review

De Burlo Group sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 3,100 shares — an estimated $535K sold.

De Burlo Group first reported a position in SLXP in Q1 2014 and held it in 5 quarters. The position peaked at $12.8M in Q3 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

De Burlo Group reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
De Burlo Group sold 3,100 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $535K.
De Burlo Group first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q1 2014 and held it in 5 quarters.
De Burlo Group's SALIX PHARMACEUTICALS LTD DEL position peaked at $12.8M in Q3 2014.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on De Burlo Group's 13F filing for Q2 2015, filed 7 Aug 2015.